{"ticker": {"uuid": "fd68790a-5abc-4621-b192-c796ac167b54", "symbol": "AZTA", "name": "Azenta Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Instruments & Supplies"}, "articles": [{"title": "Azenta announces completion of B Medical Systems sale to Thelema S.a r.l; Whitestone Group acquires a 40% Stake in Thelema S.a r.l, a Special Purpose Vehicle (SPV) established for the ownership of B Medical Systems", "summary": "Azenta, Inc. has finalized the sale of B Medical Systems S.\u00e1 r.l (BMS) to Thelema S.a r.l for $63 million in cash. As part of this transaction, Whitestone Group acquired a 40% stake in BMS through Thelema S.a r.l, investing $19 million. The acquisition aligns with Whitestone Grou", "url": "https://www.news-medical.net/news/20260710/Azenta-announces-completion-of-B-Medical-Systems-sale-to-Thelema-Sa-rl3b-Whitestone-Group-acquires-a-4025-Stake-in-Thelema-Sa-rl-a-Special-Purpose-Vehicle-(SPV)-established-for-the-ownership-of-B-Medical-Systems.aspx", "source_name": "News-Medical", "published_at": "2026-07-10T11:10:14", "published_display": "10 Jul 2026 11:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta (AZTA) After The B Medical Sale Is The New Focus Already Priced In", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-09T13:32:02+00:00", "published_display": "09 Jul 2026 13:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta completes sale of B Medical Systems for $63 million By Investing.com", "summary": "Azenta Inc. has completed the sale of its B Medical Systems business to Thelema S.\u00e0 r.l. for $63 million in cash, a move aimed at focusing on its core life sciences operations. Despite recent disappointing financial results for Q2 2026, analysts predict a return to profitability ", "url": "https://ng.investing.com/news/stock-market-news/azenta-completes-sale-of-b-medical-systems-for-63-million-93CH-2590936", "source_name": "Investing.com Nigeria", "published_at": "2026-07-08T23:43:20", "published_display": "08 Jul 2026 23:43", "sentiment": "positive", "sentiment_pct": 67, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta completes $63 million B Medical Systems sale", "summary": "Azenta (NASDAQ:AZTA) has completed the sale of its B Medical Systems business to Thelema S.\u00e0 r.l. for $63 million. This transaction, which included a $35 million vendor loan from Azenta, aligns with Azenta's strategy to streamline its portfolio and concentrate on its core life sc", "url": "https://grafa.com/en/news/united-states/azenta-sells-b-medical-systems-thelema-63-million", "source_name": "grafa.com", "published_at": "2026-07-08T16:39:17", "published_display": "08 Jul 2026 16:39", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Press Release: Azenta Completes Sale of B Medical Systems", "summary": "Azenta, Inc. (Nasdaq: AZTA) has announced the completion of the sale of its Brooks Life Sciences (BLS) consumable products and instruments business, B Medical Systems S.\u00e0 r.l. and its subsidiaries, to B Medical Systems, S.a.r.l. for approximately \u20ac145 million in cash. This strate", "url": "https://www.moomoo.com/news/post/72650605/press-release-azenta-completes-sale-of-b-medical-systems?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-07-08T12:39:16", "published_display": "08 Jul 2026 12:39", "sentiment": "positive", "sentiment_pct": 67, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta completes sale of B Medical Systems for $63 million", "summary": "Azenta Inc. has completed the sale of its B Medical Systems business to Thelema S.\u00e0 r.l. for $63 million in cash, furthering its strategy to focus on core life sciences businesses. The transaction closed on July 1, 2026, and Azenta provided a short-term vendor loan of $35 million", "url": "https://www.investing.com/news/company-news/azenta-completes-sale-of-b-medical-systems-for-63-million-93CH-4781475", "source_name": "Investing.com", "published_at": "2026-07-08T12:39:16", "published_display": "08 Jul 2026 12:39", "sentiment": "positive", "sentiment_pct": 65, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta Finalizes B Medical Divestiture With $35 Million Vendor Loan and Share Pledge", "summary": "Azenta has finalized the sale of B Medical to Thelema, involving a $35 million vendor loan from Azenta to the buyer. This loan carries 6% interest, a three-month maturity, and is secured by a first-priority pledge over 100% of B Medical's equity. This arrangement facilitates the ", "url": "https://www.tradingview.com/news/tradingview:b5350d7d6b536:0-azenta-finalizes-b-medical-divestiture-with-35-million-vendor-loan-and-share-pledge/", "source_name": "TradingView", "published_at": "2026-07-08T12:39:16", "published_display": "08 Jul 2026 12:39", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta Completes Sale of B Medical Systems", "summary": "Azenta, Inc. announced the completion of the sale of its B Medical Systems business to Thelema S.\u00e0 r.l. for $63 million in cash. This transaction, initially announced in December 2025, closed on July 1, 2026, and is part of Azenta's strategy to focus on its core life sciences bus", "url": "https://www.prnewswire.com/news-releases/azenta-completes-sale-of-b-medical-systems-302820295.html", "source_name": "PR Newswire", "published_at": "2026-07-08T11:59:55", "published_display": "08 Jul 2026 11:59", "sentiment": "positive", "sentiment_pct": 66, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Azenta\u2019s Dual Russell 2000 Defensive Index Addition Will Impact Azenta (AZTA) Investors", "summary": "Azenta, Inc. (NasdaqGS: AZTA) was recently added to both the Russell 2000 Value-Defensive Index and the Russell 2000 Defensive Index, which could increase its visibility among institutional investors. While this inclusion may boost liquidity, it does not fundamentally alter the n", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-azta/azenta/news/how-azentas-dual-russell-2000-defensive-index-addition-will", "source_name": "Simply Wall Street", "published_at": "2026-07-06T16:11:31", "published_display": "06 Jul 2026 16:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta, Inc. (AZTA) Investigation: Bronstein, Gewirtz & Grossman", "summary": "Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Azenta, Inc. (NASDAQ: AZTA) on behalf of investors. This investigation follows a significant drop in Azenta's stock price after the company reported disappointing Q2 2026 financial results, missing EPS a", "url": "https://www.natlawreview.com/press-releases/azenta-inc-azta-investigation-bronstein-gewirtz-grossman-llc-encourages", "source_name": "The National Law Review", "published_at": "2026-07-05T11:12:06", "published_display": "05 Jul 2026 11:12", "sentiment": "negative", "sentiment_pct": 12, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AZTA - Azenta Inc Options", "summary": "This article provides detailed financial data and performance metrics for Azenta Inc. (AZTA), including its stock performance, market capitalization, earnings, sales figures, and various ratios. It also lists insider and institutional ownership, analyst recommendations, and key v", "url": "https://finviz.com/stock?t=AZTA&p=d&b=1&ty=oc", "source_name": "Finviz", "published_at": "2026-07-02T20:11:04", "published_display": "02 Jul 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is There Now An Opportunity In Azenta, Inc. (NASDAQ:AZTA)?", "summary": "This article evaluates Azenta, Inc. (NASDAQ:AZTA) to determine if it presents a current investment opportunity. Given the limited content, a more detailed analysis is not possible.", "url": "https://www.moomoo.com/news/post/72192497/is-there-now-an-opportunity-in-azenta-inc-nasdaq-azta", "source_name": "Moomoo", "published_at": "2026-06-29T21:40:19", "published_display": "29 Jun 2026 21:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AZTA SEC Filings - Azenta Inc 10-K, 10-Q, 8-K Forms", "summary": "This page provides a comprehensive resource for Azenta Inc. (AZTA) SEC filings, including annual reports (10-K), quarterly earnings (10-Q), material events (8-K), and insider trading forms. Recent filings detail insider transaction amendments, sales related to RSU vesting, and a ", "url": "https://www.stocktitan.net/sec-filings/AZTA/page-5.html", "source_name": "Stock Titan", "published_at": "2026-06-29T17:42:12", "published_display": "29 Jun 2026 17:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta (NASDAQ:AZTA) Shift Puts Its Defensive Story In Focus", "summary": "Azenta (NASDAQ:AZTA) is gaining attention after its inclusion in defensive Russell benchmarks, which gives the company a clearer market identity. The company, which provides sample management, storage, and multiomics services for life sciences customers, will need to focus on ser", "url": "https://kalkinemedia.com/us/news/top-stories/azenta-nasdaqazta-shift-puts-its-defensive-story-in-focus", "source_name": "Kalkine Media", "published_at": "2026-06-29T16:39:48", "published_display": "29 Jun 2026 16:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Azenta, Inc. Stocks", "summary": "This article lists various Exchange Traded Funds (ETFs) that hold stocks of Azenta, Inc. It provides a detailed table including each fund's market value, weight of Azenta stock, issuer, management style, focus, expense ratio, assets under management (AUM), price, change percentag", "url": "https://www.tradingview.com/symbols/SWB-BA3/etfs/", "source_name": "TradingView", "published_at": "2026-06-29T13:42:12", "published_display": "29 Jun 2026 13:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does Azenta (AZTA) Joining Defensive Russell Indexes Recast Its Role as a Value-Oriented Compounder?", "summary": "Azenta, Inc. (AZTA) has been included in the Russell 2000 Defensive Index and the Russell 2000 Value-Defensive Index, which may boost its visibility and liquidity. However, this index inclusion does not change the fundamental investment narrative, which remains focused on the exe", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-azta/azenta/news/does-azenta-azta-joining-defensive-russell-indexes-recast-it", "source_name": "Simply Wall Street", "published_at": "2026-06-29T12:39:48", "published_display": "29 Jun 2026 12:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Azenta, Inc. \u2013 NASDAQ:AZTA", "summary": "This page provides financial information for Azenta, Inc. (NASDAQ: AZTA), specifically focusing on its price to sales forward metric. It also lists various sections available on TradingView related to the company, including financials, news, technicals, and forecasts.", "url": "https://www.tradingview.com/symbols/NASDAQ-AZTA/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T17:40:42", "published_display": "27 Jun 2026 17:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Azenta, Inc. \u2013 TRADEGATE:BA3", "summary": "This article briefly mentions the \"Price to earnings forward of Azenta, Inc. \u2013 TRADEGATE:BA3\" and indicates that the market is closed with no trades. It appears to be a stub or a section from a financial data platform like TradingView, lacking detailed financial analysis or figur", "url": "https://www.tradingview.com/symbols/TRADEGATE-BA3/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T06:40:42", "published_display": "27 Jun 2026 06:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Azenta, Inc. \u2013 NASDAQ:AZTA", "summary": "This article provides a financial snapshot focusing on the enterprise value to revenue forward for Azenta, Inc. (NASDAQ: AZTA). It appears to be a stub or an incomplete data point from a financial data platform, indicating the metric for the company. The content includes minimal ", "url": "https://www.tradingview.com/symbols/NASDAQ-AZTA/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T05:09:42", "published_display": "27 Jun 2026 05:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Azenta, Inc. \u2013 TRADEGATE:BA3", "summary": "The article provides the Enterprise Value to EBITDA forward for Azenta, Inc. (TRADEGATE:BA3). It indicates that the market was closed with no trades at the time of publication. The content also lists various financial tools and community features offered by TradingView.", "url": "https://www.tradingview.com/symbols/TRADEGATE-BA3/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T04:09:42", "published_display": "27 Jun 2026 04:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta, Inc. Actuals & Estimates (NASDAQ:AZTA)", "summary": "This article provides an in-depth financial overview of Azenta, Inc. (NASDAQ:AZTA), covering its stock performance, analyst forecasts, historical highs and lows, volatility, market capitalization, and upcoming earnings reports. It details recent earnings surprises, revenue figure", "url": "https://www.tradingview.com/symbols/NASDAQ-AZTA/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T07:09:42", "published_display": "26 Jun 2026 07:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta Inc Unsponsored Brazilian Depositary Receipt Repr 0.083333333 Sh Actuals & Estimates (BMFBOVESPA:A2ZT34) \u2014 TradingView", "summary": "This TradingView page provides an overview of Azenta Inc.'s unsponsored Brazilian Depositary Receipt (A2ZT34) on the BMFBOVESPA. It offers access to financial actuals and analyst estimates, including income statement, balance sheet, and cash flow data, allowing users to compare r", "url": "https://www.tradingview.com/symbols/BMFBOVESPA-A2ZT34/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T06:40:58", "published_display": "26 Jun 2026 06:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AZTA Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a detailed forecast and analysis for Azenta, Inc. (AZTA) stock, including analyst price targets, past performance, and future earnings estimates. It covers various financial metrics, such as stock price, market capitalization, EBITDA, and revenue, along with", "url": "https://www.tradingview.com/symbols/NASDAQ-AZTA/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T05:40:58", "published_display": "26 Jun 2026 05:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Bull Case For Azenta (AZTA) Could Change Following Profitability Surge And Bullish Signals \u2013 Learn Why", "summary": "Azenta (AZTA) has shown improved financial performance with increased net profit and strong operational efficiency, which could shift its investment narrative. The company's recent profitability surge and bullish technical indicators suggest strengthening investor optimism despit", "url": "https://www.sahmcapital.com/news/content/the-bull-case-for-azenta-azta-could-change-following-profitability-surge-and-bullish-signals-learn-why-2026-06-19", "source_name": "Sahm", "published_at": "2026-06-19T17:10:49", "published_display": "19 Jun 2026 17:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta Inc (AZTA) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "The article provides an earnings forecast for Azenta Inc (AZTA), noting its current earnings forecast score is 7.43, ranking 291 out of 388 in its industry. Analysts have given an average price target of $41.00, with a \"Buy\" trend recommendation based on 7 analysts. The expected ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-azta/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T22:10:31", "published_display": "17 Jun 2026 22:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta Inc (AZTA) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Azenta Inc (AZTA), listing its major shareholders and their proportional holdings, current as of May 13th. It also provides insights into institutional shareholding trends over several quarters, showing changes in the number of in", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-azta/ownership", "source_name": "TradingKey", "published_at": "2026-06-17T20:10:31", "published_display": "17 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Whether Azenta (AZTA) Is Undervalued After Recent Share Price Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxQTi1MeXRwc0VOZUhuS092WmNRQlBqVENuZGNXUU5uNGhScWJmdWZuc2I5TDNzd21CakFzSk9tOGc0TkJ0dDdoQ0tYMzZBWE9yalZCZ2VNQWpVb0FyanR4Qlg5NS1MRVZOaDJTMHVHWWVQYk5laXU1YlNab0RKMS1hTE9nVmNRS3huQ2N4M3NGWXhLMzU0WHFXSHFsdUoyX1A2ZS13LVRlNVR5XzN1NnczbWluNTIzTkVvQXpnQTdIdU5tUE9xdVF2S1psQWM4STg0X0lfcTJKY9IB3AFBVV95cUxNT1hUOVQ4cEMzN3lpTmhNYS1rUnRuQl94ZUtGbzJJYTJjdXd5N0FRMG1wS3NxQ0JhLXhaUnFBdnV5U0M0RE15QVJSTnFfSXQwZmhMdzN0R0dSMU1rT19CZlFDTFR3VHQzVmtfcGNWMXptZUZvRGNIcWF0RkVOTENnaWtacnI0Nnd0T2dmZEVReVV3bWg3dmJnN015eTZZSkl0X1RaYW9lbjdQbW9zTjluWXpNeW1ValNLSkZDdUstN21PRlVScHJCSm1NLW8xMV96NFJDdGFKREczaWVl?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Bull Case For Azenta (AZTA) Could Change Following Lowered 2026 Outlook And Multiomics Overhaul \u2013 Learn Why", "summary": "Azenta (AZTA) experienced a 3% organic revenue decline in Q2 2026, leading to a lowered full-year guidance for organic revenue and compressed adjusted EBITDA margins. The company is undergoing leadership changes, including a new President for Multiomics, and is integrating UK Bio", "url": "https://www.sahmcapital.com/news/content/the-bull-case-for-azenta-azta-could-change-following-lowered-2026-outlook-and-multiomics-overhaul-learn-why-2026-06-06", "source_name": "Sahm", "published_at": "2026-06-07T15:10:12", "published_display": "07 Jun 2026 15:10", "sentiment": "negative", "sentiment_pct": 28, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta names Trey Martin president of Multiomics business By Investing.com", "summary": "Azenta, Inc. has appointed Trey Martin as President of its Multiomics business, effective April 6, 2026, to lead the next phase of its multiomics strategy. Martin brings over 30 years of leadership experience in life sciences and previously served as CEO of Maravai Life Sciences ", "url": "https://ng.investing.com/news/company-news/azenta-names-trey-martin-president-of-multiomics-business-93CH-2428854", "source_name": "Investing.com Nigeria", "published_at": "2026-06-07T00:09:29", "published_display": "07 Jun 2026 00:09", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA", "summary": "Pomerantz LLP is investigating potential securities fraud claims against Azenta, Inc. (AZTA) on behalf of investors. This investigation follows Azenta's Q2 fiscal 2026 results, which fell short of expectations, revealing \"execution gaps\" and a \"more cautious demand environment,\" ", "url": "https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-azenta-inc---azta-302789761.html", "source_name": "PR Newswire", "published_at": "2026-06-04T13:40:10", "published_display": "04 Jun 2026 13:40", "sentiment": "negative", "sentiment_pct": 28, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Azenta Inc. (AZTA) Affects Rotational Strategy Timing", "summary": "This article analyzes Azenta Inc. (AZTA) using AI models to provide trading strategies and a multi-timeframe signal analysis. It highlights strong near and mid-term sentiment but a weak long-term outlook for AZTA, presenting specific entry, target, and stop-loss zones for positio", "url": "https://news.stocktradersdaily.com/news_release/43/How_Azenta_Inc._AZTA_Affects_Rotational_Strategy_Timing_060226085002_1780447802.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-02T20:50:00", "published_display": "02 Jun 2026 20:50", "sentiment": "positive", "sentiment_pct": 72, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta Publishes 2025 Environmental, Social, and Governance (ESG) Report", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/azenta-publishes-2025-environmental-social-200500801.html", "source_name": "PR Newswire", "published_at": "2026-05-21T20:05:00+00:00", "published_display": "21 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Winners And Losers Of Q1: Azenta (NASDAQ:AZTA) Vs The Rest Of The Drug Development Inputs & Services Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQQS03N1Y4XzJyRXVjV3FaTTJRdjFtQ0FUdjlUTHRpc2R6dnRnY3d4NVU0YmdjSnJnUGdvN0hqLWJXZU9MV1dIUEhFUG5qSHJleTluRENWMDlsTXpIRGdYRG5MNEswZlRrTXlReFZYeGFReGpHMHVVQlBnSy1yYlRIYzZyQVk3U3NadmlZQ3g1LVA5cDRaX1I3WEZIaHlJZjhWOHc?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INVESTOR ALERT: Pomerantz Law Firm Investigates ClaimsOn Behalf of Investors of Azenta, Inc. - AZTA", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxOY2NtMWJhOGxVYXpsLXZuQWtTLUozbzZkN1FXN0cwWlJaOFVMMzBpT3hHQkVaTmhEdWJLVHVYNUFvNmkzcW04SGxuNHhDc0otbEtYcHQ0U1lLZ0xnSTR1bVdxN2o2cTVtT1VWdXY3TGZPcGJNYzlkZFZrTzNIRThLN0tfVG5pSlVsOWZoMlYya3g5LXY3MGtKNzBMT1l3MkNzS1lMbUcybTU5NTFYLXpsdlpkRVJENW1vQUZYVndrbnlCUmkyaVlsVW5FTGFTSXFOTlJtMmNQYVB4T1B4bVdLaEtpd3IwZTA?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AZTA Investor Alert: Levi & Korsinsky Investigates Azenta, Inc. (AZTA) for Potential Securities Fraud", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6wFBVV95cUxNUUxadnptNVhIdC16VG4xRXJTWFNmdWxjM0VxVVFrM1dBd3IwWTJXbEZPTDAtX0VodXdQdldUeGt4el9SRG1wUDdEVXI5WEhQd3JhS2lPbTE3Y3JvRzdmbWRWaF9kbGFPaklNbFlhLW1HaWVaeVBLWEhXQ3dRNU5mZG01Qm1iTm42c2R1NXN5QlQ0a2RPM2ZtMjlQbXlZblNzc0dBc24zUUxGdGVfUkJYUmVMeDFDUkNHLU5xT2ZlLVZibEFkbHpPWEwyYm9IWFFsSEEyODBFTW9INmdOVzRocHBMby1fMDZUQjQ4?oc=5", "source_name": "Morningstar", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: Azenta Q2 2026 results disappoint, stock tumbles", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxNdDZCMFVWUHpsbGFjSnRfZk1GUE40NWtyY05TZ0dOU3hoSHhLYkNSVnVIcUFMTDBEc0VTRGdxYmpUZjlBTi1LVDJCME85OU5xOWZfU1RSWUVDaVBJcU9tNDlSaHQzTG5tazN4YkVUc280M2plb0U3THBfTVFPUVlCdEhEdFZJYVdBVDczdnl4LUtIZ0JhaWNOeS1EQllvTW9iS2luRVFpRlJCREJBc1RoMGxYczJYeE03QVNKbFU4ZHQwUmpST1Vz?oc=5", "source_name": "Investing.com", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta, Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Azenta, Inc. (AZTA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_gFBVV95cUxQRFg4R1dWQTloYXNac0pnR0RVaG1NcTZ6OFlIQnpHSm5MQXJ0VE5DOWMxM1BRc2R2Q2lacnU2a3h2R3JDUWhpWFRLNXNKME84aDA2bExzelZaeVNCRVlrTFJPU3RPMmNpRDZiR1dvVGdlcU40cU5BNm05aHhzQms4by14WWtWbUhEb0JzMXBKbTdZcTdDUUNMX1djbTJ5VkxJaUtiaVZ6Y2xNX3pRV0UyWThkTUUyV0x3dGFGZTNabXFGc1FIQWxLMTBzMTNkX1pwMEFjN1Jsa2E4RWhqZU1DOGVycjNndFBEMkQwbEtYWENoSWdzbkppeklfQlA3Zw?oc=5", "source_name": "Morningstar", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta\u2019s Q1 Earnings Call: Our Top 5 Analyst Questions", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOdHphcGFhSXd3MHJtdkVBeDl4OC1hbUYwWEMwb002VXVfcDdpNWZBX0ZncjJwaTZIZ1NuQTZBUms4bUE2RUhSNnBzdDhpTHdBTjBsMlFGZDI4eVFQM0xQV1hUck5rbEIzb3JHZTZfeHRobTc0dTA2alBBUFBoc01yOFdMY1YwQldobG1OVTRFSE9CbDRwdDQwckxZV1NjXzNZazluQUE2NHd1bUQtc1B5OEZDYzliZ3c?oc=5", "source_name": "StockStory", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta, Inc. Q2 2026 Earnings Call Summary", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNWDg2bzZObXFtS3VieGZkVUQtemF5VkdOczlmdkxCMWJWLWVZMjQ4YjhBYkRJTGJOcUt2aV9VeTRGaXRFQ1JXMFgwQWFmSUU3RnA2YUswM1FIRWR2UG0yVVRqMXE0dl8wTHJUZnRpeFJiWUdLY3hRXzhLeXZXMkhpa3FtM21tUlJfZDdSbVYzWGZFUEZXY1NN?oc=5", "source_name": "Market source", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta Q2 Earnings Call Highlights", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPa3doeVJCTlp3S09TQnZQY3BhMDN4cW1LVHlHVmI1SXBjNFVSQk1IdGs2NjFaQktyVWp5cmlhdkJ4U1FSOExrM29VYWpNMmRfbkZBXzlWS0pfTVdGZkdZaG94LXVURVc0b1NrV2Rpcm95cG04WVItWTI5NU1Gaks1OWNvUWFwLWFwd2l2cnkySVpyb0RHdkVsbE4tUk1SZzRsanEzQ1BB?oc=5", "source_name": "Market source", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta Q2 2026 slides: revenue miss, $149M impairment trigger 22% drop", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNTGZwNWdGajE0bXBQV0p6QUc5NnBoOUx0SzhrdjJLWEJ3ZUEtM01QWUFyd1hfOFJCZzZzTHdrMlJuUWs0VVZqdzF0MndDcDNfcVhZNjUwNEl6TFdOWmgtYmRJM1hZOWtxQXRWU1FHbEJBcm0zeUFyNGx1S29xekRDYVRTQk5pZnpHMWpzc3F6ai04cGVqTFR0OFB3RUhZMVBTaGtmNGk4VHVCZ1dER0VMRnlCZEwwOG9GcEdtMEJRbzg?oc=5", "source_name": "Investing.com", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta (AZTA) Quarterly Loss Of US$157 Million Reinforces Bearish Margin Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta Reports Second Quarter Results for Fiscal 2026, Ended March 31, 2026, Updates Full Year Fiscal 2026 Guidance, and Extends Long-Range Plan to 2029", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAJBVV95cUxOQUk0UEhRbUNyMFhhb05zMFRiQjZOamtsVmpQdmNyWVNFOHVsZ19kLVFjcXFqMjBPTTN6MUxnVjU4c1ZNaVRxWmdBWGtlTFBGQTM3Qlk0Zkt2OElFTG9IZDVSNFkxUHM1MDB4WDJ0OEs2eWxKLUpQU1lKUXAtRVJmUGJBRmVtZFA2RHdMTm0tN2VkRmRhWFpPRVZoZG9TOWUyVnd6OG5mWU1Vb3VMNG1VOURraEstaDZ3UERKLWRyX0wzcGg3SDlpVWktZU9HXzNsWUpGTUktZmVJTzhJNmJyb3Q5a3A3ZGo1ZEt2TUpuNTVxNWhDbmdvMjZCY05zcFpPTmVweHo0V1ExQTJoRy1VRjlwcFN2ZmN4c3lhX0FDQ0dkTWNoYjE5NWNETjk?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta Q2 2026 Earnings Preview \u2014 Street Expects $0.14 EPS", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxQLUw4M2pkMzh0RHY2VnVFTExUcUpyQ3IyTEQwMUVnVGJjNDFmbnNMT3BReF9hV3Jhci1LM195Z3gyVFhmMllBcm9rbkdobW5Ub05lM1FDaDd5UC1RN0o2bzRPZzRUeHl3WjFPVFZWT2d6d3RjVXlYank3dVUtNXhKV19ySHpKZkJoQmVWaFhn0gGOAUFVX3lxTFAtTDgzamQzOHREdjZWdUVMTFRxSnJDcjJMRDAxRWdUYmM0MWZuc0xPcFF4X2FXcmFyLUszX3lneDJUWGYyWUFyb2tuR2htblRvTmUzUUNoN3lQLVE3SjZvNE9nNFR4eXdaMU9UVlZPZ3p3dGNVeVhqeTd1VS01eEpXX3JIekpmQmhCZVZoWGc?oc=5", "source_name": "AlphaStreet", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Azenta (AZTA) Investment Narrative Is Shifting As Analysts Recut Valuation Targets", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQZ2M0eVlxMjBnOUJDNGdfUHVmN1ljWWg4Wk9malhoOGczNG44RG9CNTNfSXpZaWptV1RRV2Y1QWJhaGFKLWN4aTlvWlZhWnNWTTlmNzlVSW5wM25ZeG9rS0FQenViNU1YYkZEV1EyaXlMV25ua0JOLWVoWkgyd0hqcHIyc3ZsaFprTWRvQjQ4cE1TdlhaMXVHV3dfcEdzODQzM3JYeEstZ25Wdw?oc=5", "source_name": "Market source", "published_at": "2026-05-03T07:00:00+00:00", "published_display": "03 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Azenta (AZTA) Valuation After Recent Share Price Volatility", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPVWsya1RXcG1BME16dlFKanI1NjNCNmFUdndYUlpoNHpabG1lV0lJRzhTX3BjdDJ3OGtWMzUzY25TZWNiMVRoY09EamdRZ3lfb3pLYjBYTFhBUXlkUGRqQldPNi1DbTdBRHZBRzhiekJrOEpPOW5Rck1fOUVMQ00ta0lHb0xRdTFJd2ZYUmoyMWY0RnVUaUZMZnhIVDRHdTRUTUVBcV9n?oc=5", "source_name": "Market source", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta (AZTA) Fell on Operational Challenges and Uneven Execution", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQRTNTZmFtOGJRQmU4dUpUZVB5eC1GbGZOWG9ScWZndHBHc2RJQl9DRFRocGxCUFlSUTdxR0lDRzE5c05rT3ZYdHFUMjhyMG1uRFZtYUFpUUNYN2dtc3ZrenZzdFdWUEdxVnJjTWhKLUR5UGZtYlVzcHlKdWR5b09WVHBCamQzN3BnTnpxZEMzT2xrUFFLZ29ueVRqMUp6RkUtRlJzRXNuaw?oc=5", "source_name": "Market source", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Azenta (AZTA) Valuation After A Short-Term Rebound And Longer-Term Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNYW1LR0pjQW92ZWVnejBfRkhuMWMwQlI4UXZIT2VMUUg3VE4wZDF5ZlBkQVAzQkgwTzQyUGhNNHFIY3VzSXJqRld5NVpWcmI1c21UbXNoRHI0U1U5WWh6OTNSVHdNSDRmSXRlek1qcXBGM2ZMSXhZMUZGU0ZJTVBsQUVJVGlyM0l3REt4aXhST24zMlNDQUdfaGZOTUR6Mk1BeTBVMA?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna Shares Plummet, What You Need To Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNTTYtaVhDaGh0R09DeEEtc0wzRGYxeGtWdERRT00tZXl2cG53VkdnWWh6UmdTMjRIOWVxQWh1Wmc2VFlYVWRFQ3VXdjEzT2JQV0Y5MEtsbHhWQlAwYnM3VUJjdUprZi1ncWlqNmpTcTVxVXplZmtXckx3WjZIQVp2VkVOVEpkUjF3WjlWU3JHbi01Nmh1dXdrTUFteDhaUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is Azenta (AZTA) Trading So Low Despite Strong Balance Sheet", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOaGhNVzZGRE1HWnlXR0F0UXdPV3NTNXVpMkNPNFNSbUp1MHlwNVNDcENOSmZ2M2dyYy1oeGlDbDkySWV6OVk3Nk16VjhZREFLcTFrdVZLcDRGRXhwb3FqRmxIUkxaZEJYUzV3WUcxUzRHM3NTTFBuVW5Qb0gzRk0yYl9hQWg3aVl4dm5abHA5QWxRVkc3WDd6N3VrbXFIQQ?oc=5", "source_name": "Kavout | AI", "published_at": "2026-03-25T01:54:47+00:00", "published_display": "25 Mar 2026 01:54", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Has Azenta (AZTA) Fallen Too Far After Recent Share Price Weakness?", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE94aUlyT2lBVEVacGFSYTByMlFMUWRmaTdYcW5uQWlZTUxEN19wTEJuLVd3MU1SMXdaVWRZZVR1NldfRzFmMjV5MWNMTGZTN0JtZ1pac25yUmVIb2Z6WmNDSWtySXllV29aLWlGSnd0UUE1NHZaeDU3em85LWg?oc=5", "source_name": "Market source", "published_at": "2026-03-14T07:00:00+00:00", "published_display": "14 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace, Revvity, Azenta, Bio-Techne, and Oscar Health Stocks Trade Down, What You Need To Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNWjVYSmRLMFdQZ3I2ZkRNeEo5aFBFdVhSV3hvNXNfRzFRMjMybkd1aTF2d19KREI3dUJVa2d4VjJSSFc1RVFsa3JCZHhwM3JHeWVJQmlPOVpzd1RGMFE3M3R3dHRPY2JmYmw0Xy1mWFV3OHVoNkx1VVNmRE9qU1U1YjFOMnp4UQ?oc=5", "source_name": "Market source", "published_at": "2026-02-23T08:00:00+00:00", "published_display": "23 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does Azenta (AZTA) Earnings, Buyback Pause, and Board Change Hint at a Strategic Crossroads?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNWldvazlRTkd1Q09MOE9vMVdvSkxCTWh0d3p6aWVSeVhjV0t2OUQxbnA1NVdKQkI0Z1dkR3dDN2NXWmEwRG9vTjBHdnZyRE4yZTZvaUcxN1R3LXpwMzU4Tjk5QjhEckFOMElYSHFibzZCaUJLVjZ4TFJGZFh2WnFEOUMyZUFCZw?oc=5", "source_name": "Market source", "published_at": "2026-02-09T08:00:00+00:00", "published_display": "09 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta (AZTA) Stock Trades Down, Here Is Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxQLThMcXM4dnBfMGRyR0E3M195RU9qcVJHMzFxQmdBRXJzd212THpJamVMcm9VUUh2VjBfeVNpcVEzVlpGNHY2eEt4NHlrX2dGSVZFM3V2Z05makMtZWkyOHF3dTk5M3l3YzVxTk12akZfOTROUWRvUGRLMHhzeXgwUw?oc=5", "source_name": "Market source", "published_at": "2026-02-04T08:00:00+00:00", "published_display": "04 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Azenta announces completion of B Medical Systems sale to Thelema S.a r.l; Whitestone Group acquires a 40% Stake in Thelema S.a r.l, a Special Purpose Vehicle (SPV) established for the ownership of B Medical Systems", "summary": "Azenta, Inc. has finalized the sale of B Medical Systems S.\u00e1 r.l (BMS) to Thelema S.a r.l for $63 million in cash. As part of this transaction, Whitestone Group acquired a 40% stake in BMS through Thelema S.a r.l, investing $19 million. The acquisition aligns with Whitestone Grou", "url": "https://www.news-medical.net/news/20260710/Azenta-announces-completion-of-B-Medical-Systems-sale-to-Thelema-Sa-rl3b-Whitestone-Group-acquires-a-4025-Stake-in-Thelema-Sa-rl-a-Special-Purpose-Vehicle-(SPV)-established-for-the-ownership-of-B-Medical-Systems.aspx", "source_name": "News-Medical", "published_at": "2026-07-10T11:10:14", "published_display": "10 Jul 2026 11:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta (AZTA) After The B Medical Sale Is The New Focus Already Priced In", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-09T13:32:02+00:00", "published_display": "09 Jul 2026 13:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta completes sale of B Medical Systems for $63 million By Investing.com", "summary": "Azenta Inc. has completed the sale of its B Medical Systems business to Thelema S.\u00e0 r.l. for $63 million in cash, a move aimed at focusing on its core life sciences operations. Despite recent disappointing financial results for Q2 2026, analysts predict a return to profitability ", "url": "https://ng.investing.com/news/stock-market-news/azenta-completes-sale-of-b-medical-systems-for-63-million-93CH-2590936", "source_name": "Investing.com Nigeria", "published_at": "2026-07-08T23:43:20", "published_display": "08 Jul 2026 23:43", "sentiment": "positive", "sentiment_pct": 67, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta completes $63 million B Medical Systems sale", "summary": "Azenta (NASDAQ:AZTA) has completed the sale of its B Medical Systems business to Thelema S.\u00e0 r.l. for $63 million. This transaction, which included a $35 million vendor loan from Azenta, aligns with Azenta's strategy to streamline its portfolio and concentrate on its core life sc", "url": "https://grafa.com/en/news/united-states/azenta-sells-b-medical-systems-thelema-63-million", "source_name": "grafa.com", "published_at": "2026-07-08T16:39:17", "published_display": "08 Jul 2026 16:39", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Press Release: Azenta Completes Sale of B Medical Systems", "summary": "Azenta, Inc. (Nasdaq: AZTA) has announced the completion of the sale of its Brooks Life Sciences (BLS) consumable products and instruments business, B Medical Systems S.\u00e0 r.l. and its subsidiaries, to B Medical Systems, S.a.r.l. for approximately \u20ac145 million in cash. This strate", "url": "https://www.moomoo.com/news/post/72650605/press-release-azenta-completes-sale-of-b-medical-systems?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-07-08T12:39:16", "published_display": "08 Jul 2026 12:39", "sentiment": "positive", "sentiment_pct": 67, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta completes sale of B Medical Systems for $63 million", "summary": "Azenta Inc. has completed the sale of its B Medical Systems business to Thelema S.\u00e0 r.l. for $63 million in cash, furthering its strategy to focus on core life sciences businesses. The transaction closed on July 1, 2026, and Azenta provided a short-term vendor loan of $35 million", "url": "https://www.investing.com/news/company-news/azenta-completes-sale-of-b-medical-systems-for-63-million-93CH-4781475", "source_name": "Investing.com", "published_at": "2026-07-08T12:39:16", "published_display": "08 Jul 2026 12:39", "sentiment": "positive", "sentiment_pct": 65, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta Finalizes B Medical Divestiture With $35 Million Vendor Loan and Share Pledge", "summary": "Azenta has finalized the sale of B Medical to Thelema, involving a $35 million vendor loan from Azenta to the buyer. This loan carries 6% interest, a three-month maturity, and is secured by a first-priority pledge over 100% of B Medical's equity. This arrangement facilitates the ", "url": "https://www.tradingview.com/news/tradingview:b5350d7d6b536:0-azenta-finalizes-b-medical-divestiture-with-35-million-vendor-loan-and-share-pledge/", "source_name": "TradingView", "published_at": "2026-07-08T12:39:16", "published_display": "08 Jul 2026 12:39", "sentiment": "positive", "sentiment_pct": 62, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta Completes Sale of B Medical Systems", "summary": "Azenta, Inc. announced the completion of the sale of its B Medical Systems business to Thelema S.\u00e0 r.l. for $63 million in cash. This transaction, initially announced in December 2025, closed on July 1, 2026, and is part of Azenta's strategy to focus on its core life sciences bus", "url": "https://www.prnewswire.com/news-releases/azenta-completes-sale-of-b-medical-systems-302820295.html", "source_name": "PR Newswire", "published_at": "2026-07-08T11:59:55", "published_display": "08 Jul 2026 11:59", "sentiment": "positive", "sentiment_pct": 66, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Azenta\u2019s Dual Russell 2000 Defensive Index Addition Will Impact Azenta (AZTA) Investors", "summary": "Azenta, Inc. (NasdaqGS: AZTA) was recently added to both the Russell 2000 Value-Defensive Index and the Russell 2000 Defensive Index, which could increase its visibility among institutional investors. While this inclusion may boost liquidity, it does not fundamentally alter the n", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-azta/azenta/news/how-azentas-dual-russell-2000-defensive-index-addition-will", "source_name": "Simply Wall Street", "published_at": "2026-07-06T16:11:31", "published_display": "06 Jul 2026 16:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta, Inc. (AZTA) Investigation: Bronstein, Gewirtz & Grossman", "summary": "Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Azenta, Inc. (NASDAQ: AZTA) on behalf of investors. This investigation follows a significant drop in Azenta's stock price after the company reported disappointing Q2 2026 financial results, missing EPS a", "url": "https://www.natlawreview.com/press-releases/azenta-inc-azta-investigation-bronstein-gewirtz-grossman-llc-encourages", "source_name": "The National Law Review", "published_at": "2026-07-05T11:12:06", "published_display": "05 Jul 2026 11:12", "sentiment": "negative", "sentiment_pct": 12, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AZTA - Azenta Inc Options", "summary": "This article provides detailed financial data and performance metrics for Azenta Inc. (AZTA), including its stock performance, market capitalization, earnings, sales figures, and various ratios. It also lists insider and institutional ownership, analyst recommendations, and key v", "url": "https://finviz.com/stock?t=AZTA&p=d&b=1&ty=oc", "source_name": "Finviz", "published_at": "2026-07-02T20:11:04", "published_display": "02 Jul 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is There Now An Opportunity In Azenta, Inc. (NASDAQ:AZTA)?", "summary": "This article evaluates Azenta, Inc. (NASDAQ:AZTA) to determine if it presents a current investment opportunity. Given the limited content, a more detailed analysis is not possible.", "url": "https://www.moomoo.com/news/post/72192497/is-there-now-an-opportunity-in-azenta-inc-nasdaq-azta", "source_name": "Moomoo", "published_at": "2026-06-29T21:40:19", "published_display": "29 Jun 2026 21:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AZTA SEC Filings - Azenta Inc 10-K, 10-Q, 8-K Forms", "summary": "This page provides a comprehensive resource for Azenta Inc. (AZTA) SEC filings, including annual reports (10-K), quarterly earnings (10-Q), material events (8-K), and insider trading forms. Recent filings detail insider transaction amendments, sales related to RSU vesting, and a ", "url": "https://www.stocktitan.net/sec-filings/AZTA/page-5.html", "source_name": "Stock Titan", "published_at": "2026-06-29T17:42:12", "published_display": "29 Jun 2026 17:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta (NASDAQ:AZTA) Shift Puts Its Defensive Story In Focus", "summary": "Azenta (NASDAQ:AZTA) is gaining attention after its inclusion in defensive Russell benchmarks, which gives the company a clearer market identity. The company, which provides sample management, storage, and multiomics services for life sciences customers, will need to focus on ser", "url": "https://kalkinemedia.com/us/news/top-stories/azenta-nasdaqazta-shift-puts-its-defensive-story-in-focus", "source_name": "Kalkine Media", "published_at": "2026-06-29T16:39:48", "published_display": "29 Jun 2026 16:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Azenta, Inc. Stocks", "summary": "This article lists various Exchange Traded Funds (ETFs) that hold stocks of Azenta, Inc. It provides a detailed table including each fund's market value, weight of Azenta stock, issuer, management style, focus, expense ratio, assets under management (AUM), price, change percentag", "url": "https://www.tradingview.com/symbols/SWB-BA3/etfs/", "source_name": "TradingView", "published_at": "2026-06-29T13:42:12", "published_display": "29 Jun 2026 13:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does Azenta (AZTA) Joining Defensive Russell Indexes Recast Its Role as a Value-Oriented Compounder?", "summary": "Azenta, Inc. (AZTA) has been included in the Russell 2000 Defensive Index and the Russell 2000 Value-Defensive Index, which may boost its visibility and liquidity. However, this index inclusion does not change the fundamental investment narrative, which remains focused on the exe", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-azta/azenta/news/does-azenta-azta-joining-defensive-russell-indexes-recast-it", "source_name": "Simply Wall Street", "published_at": "2026-06-29T12:39:48", "published_display": "29 Jun 2026 12:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Azenta, Inc. \u2013 NASDAQ:AZTA", "summary": "This page provides financial information for Azenta, Inc. (NASDAQ: AZTA), specifically focusing on its price to sales forward metric. It also lists various sections available on TradingView related to the company, including financials, news, technicals, and forecasts.", "url": "https://www.tradingview.com/symbols/NASDAQ-AZTA/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T17:40:42", "published_display": "27 Jun 2026 17:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Azenta, Inc. \u2013 TRADEGATE:BA3", "summary": "This article briefly mentions the \"Price to earnings forward of Azenta, Inc. \u2013 TRADEGATE:BA3\" and indicates that the market is closed with no trades. It appears to be a stub or a section from a financial data platform like TradingView, lacking detailed financial analysis or figur", "url": "https://www.tradingview.com/symbols/TRADEGATE-BA3/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T06:40:42", "published_display": "27 Jun 2026 06:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Azenta, Inc. \u2013 NASDAQ:AZTA", "summary": "This article provides a financial snapshot focusing on the enterprise value to revenue forward for Azenta, Inc. (NASDAQ: AZTA). It appears to be a stub or an incomplete data point from a financial data platform, indicating the metric for the company. The content includes minimal ", "url": "https://www.tradingview.com/symbols/NASDAQ-AZTA/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T05:09:42", "published_display": "27 Jun 2026 05:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Azenta, Inc. \u2013 TRADEGATE:BA3", "summary": "The article provides the Enterprise Value to EBITDA forward for Azenta, Inc. (TRADEGATE:BA3). It indicates that the market was closed with no trades at the time of publication. The content also lists various financial tools and community features offered by TradingView.", "url": "https://www.tradingview.com/symbols/TRADEGATE-BA3/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T04:09:42", "published_display": "27 Jun 2026 04:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta, Inc. Actuals & Estimates (NASDAQ:AZTA)", "summary": "This article provides an in-depth financial overview of Azenta, Inc. (NASDAQ:AZTA), covering its stock performance, analyst forecasts, historical highs and lows, volatility, market capitalization, and upcoming earnings reports. It details recent earnings surprises, revenue figure", "url": "https://www.tradingview.com/symbols/NASDAQ-AZTA/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T07:09:42", "published_display": "26 Jun 2026 07:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta Inc Unsponsored Brazilian Depositary Receipt Repr 0.083333333 Sh Actuals & Estimates (BMFBOVESPA:A2ZT34) \u2014 TradingView", "summary": "This TradingView page provides an overview of Azenta Inc.'s unsponsored Brazilian Depositary Receipt (A2ZT34) on the BMFBOVESPA. It offers access to financial actuals and analyst estimates, including income statement, balance sheet, and cash flow data, allowing users to compare r", "url": "https://www.tradingview.com/symbols/BMFBOVESPA-A2ZT34/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T06:40:58", "published_display": "26 Jun 2026 06:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AZTA Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a detailed forecast and analysis for Azenta, Inc. (AZTA) stock, including analyst price targets, past performance, and future earnings estimates. It covers various financial metrics, such as stock price, market capitalization, EBITDA, and revenue, along with", "url": "https://www.tradingview.com/symbols/NASDAQ-AZTA/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T05:40:58", "published_display": "26 Jun 2026 05:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Bull Case For Azenta (AZTA) Could Change Following Profitability Surge And Bullish Signals \u2013 Learn Why", "summary": "Azenta (AZTA) has shown improved financial performance with increased net profit and strong operational efficiency, which could shift its investment narrative. The company's recent profitability surge and bullish technical indicators suggest strengthening investor optimism despit", "url": "https://www.sahmcapital.com/news/content/the-bull-case-for-azenta-azta-could-change-following-profitability-surge-and-bullish-signals-learn-why-2026-06-19", "source_name": "Sahm", "published_at": "2026-06-19T17:10:49", "published_display": "19 Jun 2026 17:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta Inc (AZTA) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "The article provides an earnings forecast for Azenta Inc (AZTA), noting its current earnings forecast score is 7.43, ranking 291 out of 388 in its industry. Analysts have given an average price target of $41.00, with a \"Buy\" trend recommendation based on 7 analysts. The expected ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-azta/earnings", "source_name": "TradingKey", "published_at": "2026-06-17T22:10:31", "published_display": "17 Jun 2026 22:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta Inc (AZTA) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Azenta Inc (AZTA), listing its major shareholders and their proportional holdings, current as of May 13th. It also provides insights into institutional shareholding trends over several quarters, showing changes in the number of in", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-azta/ownership", "source_name": "TradingKey", "published_at": "2026-06-17T20:10:31", "published_display": "17 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Whether Azenta (AZTA) Is Undervalued After Recent Share Price Momentum", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Bull Case For Azenta (AZTA) Could Change Following Lowered 2026 Outlook And Multiomics Overhaul \u2013 Learn Why", "summary": "Azenta (AZTA) experienced a 3% organic revenue decline in Q2 2026, leading to a lowered full-year guidance for organic revenue and compressed adjusted EBITDA margins. The company is undergoing leadership changes, including a new President for Multiomics, and is integrating UK Bio", "url": "https://www.sahmcapital.com/news/content/the-bull-case-for-azenta-azta-could-change-following-lowered-2026-outlook-and-multiomics-overhaul-learn-why-2026-06-06", "source_name": "Sahm", "published_at": "2026-06-07T15:10:12", "published_display": "07 Jun 2026 15:10", "sentiment": "negative", "sentiment_pct": 28, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta names Trey Martin president of Multiomics business By Investing.com", "summary": "Azenta, Inc. has appointed Trey Martin as President of its Multiomics business, effective April 6, 2026, to lead the next phase of its multiomics strategy. Martin brings over 30 years of leadership experience in life sciences and previously served as CEO of Maravai Life Sciences ", "url": "https://ng.investing.com/news/company-news/azenta-names-trey-martin-president-of-multiomics-business-93CH-2428854", "source_name": "Investing.com Nigeria", "published_at": "2026-06-07T00:09:29", "published_display": "07 Jun 2026 00:09", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA", "summary": "Pomerantz LLP is investigating potential securities fraud claims against Azenta, Inc. (AZTA) on behalf of investors. This investigation follows Azenta's Q2 fiscal 2026 results, which fell short of expectations, revealing \"execution gaps\" and a \"more cautious demand environment,\" ", "url": "https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-azenta-inc---azta-302789761.html", "source_name": "PR Newswire", "published_at": "2026-06-04T13:40:10", "published_display": "04 Jun 2026 13:40", "sentiment": "negative", "sentiment_pct": 28, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Azenta Inc. (AZTA) Affects Rotational Strategy Timing", "summary": "This article analyzes Azenta Inc. (AZTA) using AI models to provide trading strategies and a multi-timeframe signal analysis. It highlights strong near and mid-term sentiment but a weak long-term outlook for AZTA, presenting specific entry, target, and stop-loss zones for positio", "url": "https://news.stocktradersdaily.com/news_release/43/How_Azenta_Inc._AZTA_Affects_Rotational_Strategy_Timing_060226085002_1780447802.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-02T20:50:00", "published_display": "02 Jun 2026 20:50", "sentiment": "positive", "sentiment_pct": 72, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta Publishes 2025 Environmental, Social, and Governance (ESG) Report", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/azenta-publishes-2025-environmental-social-200500801.html", "source_name": "PR Newswire", "published_at": "2026-05-21T20:05:00+00:00", "published_display": "21 May 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Winners And Losers Of Q1: Azenta (NASDAQ:AZTA) Vs The Rest Of The Drug Development Inputs & Services Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQQS03N1Y4XzJyRXVjV3FaTTJRdjFtQ0FUdjlUTHRpc2R6dnRnY3d4NVU0YmdjSnJnUGdvN0hqLWJXZU9MV1dIUEhFUG5qSHJleTluRENWMDlsTXpIRGdYRG5MNEswZlRrTXlReFZYeGFReGpHMHVVQlBnSy1yYlRIYzZyQVk3U3NadmlZQ3g1LVA5cDRaX1I3WEZIaHlJZjhWOHc?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "INVESTOR ALERT: Pomerantz Law Firm Investigates ClaimsOn Behalf of Investors of Azenta, Inc. - AZTA", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxOY2NtMWJhOGxVYXpsLXZuQWtTLUozbzZkN1FXN0cwWlJaOFVMMzBpT3hHQkVaTmhEdWJLVHVYNUFvNmkzcW04SGxuNHhDc0otbEtYcHQ0U1lLZ0xnSTR1bVdxN2o2cTVtT1VWdXY3TGZPcGJNYzlkZFZrTzNIRThLN0tfVG5pSlVsOWZoMlYya3g5LXY3MGtKNzBMT1l3MkNzS1lMbUcybTU5NTFYLXpsdlpkRVJENW1vQUZYVndrbnlCUmkyaVlsVW5FTGFTSXFOTlJtMmNQYVB4T1B4bVdLaEtpd3IwZTA?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AZTA Investor Alert: Levi & Korsinsky Investigates Azenta, Inc. (AZTA) for Potential Securities Fraud", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6wFBVV95cUxNUUxadnptNVhIdC16VG4xRXJTWFNmdWxjM0VxVVFrM1dBd3IwWTJXbEZPTDAtX0VodXdQdldUeGt4el9SRG1wUDdEVXI5WEhQd3JhS2lPbTE3Y3JvRzdmbWRWaF9kbGFPaklNbFlhLW1HaWVaeVBLWEhXQ3dRNU5mZG01Qm1iTm42c2R1NXN5QlQ0a2RPM2ZtMjlQbXlZblNzc0dBc24zUUxGdGVfUkJYUmVMeDFDUkNHLU5xT2ZlLVZibEFkbHpPWEwyYm9IWFFsSEEyODBFTW9INmdOVzRocHBMby1fMDZUQjQ4?oc=5", "source_name": "Morningstar", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: Azenta Q2 2026 results disappoint, stock tumbles", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxNdDZCMFVWUHpsbGFjSnRfZk1GUE40NWtyY05TZ0dOU3hoSHhLYkNSVnVIcUFMTDBEc0VTRGdxYmpUZjlBTi1LVDJCME85OU5xOWZfU1RSWUVDaVBJcU9tNDlSaHQzTG5tazN4YkVUc280M2plb0U3THBfTVFPUVlCdEhEdFZJYVdBVDczdnl4LUtIZ0JhaWNOeS1EQllvTW9iS2luRVFpRlJCREJBc1RoMGxYczJYeE03QVNKbFU4ZHQwUmpST1Vz?oc=5", "source_name": "Investing.com", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta, Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Azenta, Inc. (AZTA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi_gFBVV95cUxQRFg4R1dWQTloYXNac0pnR0RVaG1NcTZ6OFlIQnpHSm5MQXJ0VE5DOWMxM1BRc2R2Q2lacnU2a3h2R3JDUWhpWFRLNXNKME84aDA2bExzelZaeVNCRVlrTFJPU3RPMmNpRDZiR1dvVGdlcU40cU5BNm05aHhzQms4by14WWtWbUhEb0JzMXBKbTdZcTdDUUNMX1djbTJ5VkxJaUtiaVZ6Y2xNX3pRV0UyWThkTUUyV0x3dGFGZTNabXFGc1FIQWxLMTBzMTNkX1pwMEFjN1Jsa2E4RWhqZU1DOGVycjNndFBEMkQwbEtYWENoSWdzbkppeklfQlA3Zw?oc=5", "source_name": "Morningstar", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta\u2019s Q1 Earnings Call: Our Top 5 Analyst Questions", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOdHphcGFhSXd3MHJtdkVBeDl4OC1hbUYwWEMwb002VXVfcDdpNWZBX0ZncjJwaTZIZ1NuQTZBUms4bUE2RUhSNnBzdDhpTHdBTjBsMlFGZDI4eVFQM0xQV1hUck5rbEIzb3JHZTZfeHRobTc0dTA2alBBUFBoc01yOFdMY1YwQldobG1OVTRFSE9CbDRwdDQwckxZV1NjXzNZazluQUE2NHd1bUQtc1B5OEZDYzliZ3c?oc=5", "source_name": "StockStory", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta, Inc. Q2 2026 Earnings Call Summary", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNWDg2bzZObXFtS3VieGZkVUQtemF5VkdOczlmdkxCMWJWLWVZMjQ4YjhBYkRJTGJOcUt2aV9VeTRGaXRFQ1JXMFgwQWFmSUU3RnA2YUswM1FIRWR2UG0yVVRqMXE0dl8wTHJUZnRpeFJiWUdLY3hRXzhLeXZXMkhpa3FtM21tUlJfZDdSbVYzWGZFUEZXY1NN?oc=5", "source_name": "Market source", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta Q2 Earnings Call Highlights", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPa3doeVJCTlp3S09TQnZQY3BhMDN4cW1LVHlHVmI1SXBjNFVSQk1IdGs2NjFaQktyVWp5cmlhdkJ4U1FSOExrM29VYWpNMmRfbkZBXzlWS0pfTVdGZkdZaG94LXVURVc0b1NrV2Rpcm95cG04WVItWTI5NU1Gaks1OWNvUWFwLWFwd2l2cnkySVpyb0RHdkVsbE4tUk1SZzRsanEzQ1BB?oc=5", "source_name": "Market source", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta Q2 2026 slides: revenue miss, $149M impairment trigger 22% drop", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNTGZwNWdGajE0bXBQV0p6QUc5NnBoOUx0SzhrdjJLWEJ3ZUEtM01QWUFyd1hfOFJCZzZzTHdrMlJuUWs0VVZqdzF0MndDcDNfcVhZNjUwNEl6TFdOWmgtYmRJM1hZOWtxQXRWU1FHbEJBcm0zeUFyNGx1S29xekRDYVRTQk5pZnpHMWpzc3F6ai04cGVqTFR0OFB3RUhZMVBTaGtmNGk4VHVCZ1dER0VMRnlCZEwwOG9GcEdtMEJRbzg?oc=5", "source_name": "Investing.com", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta (AZTA) Quarterly Loss Of US$157 Million Reinforces Bearish Margin Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta Reports Second Quarter Results for Fiscal 2026, Ended March 31, 2026, Updates Full Year Fiscal 2026 Guidance, and Extends Long-Range Plan to 2029", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAJBVV95cUxOQUk0UEhRbUNyMFhhb05zMFRiQjZOamtsVmpQdmNyWVNFOHVsZ19kLVFjcXFqMjBPTTN6MUxnVjU4c1ZNaVRxWmdBWGtlTFBGQTM3Qlk0Zkt2OElFTG9IZDVSNFkxUHM1MDB4WDJ0OEs2eWxKLUpQU1lKUXAtRVJmUGJBRmVtZFA2RHdMTm0tN2VkRmRhWFpPRVZoZG9TOWUyVnd6OG5mWU1Vb3VMNG1VOURraEstaDZ3UERKLWRyX0wzcGg3SDlpVWktZU9HXzNsWUpGTUktZmVJTzhJNmJyb3Q5a3A3ZGo1ZEt2TUpuNTVxNWhDbmdvMjZCY05zcFpPTmVweHo0V1ExQTJoRy1VRjlwcFN2ZmN4c3lhX0FDQ0dkTWNoYjE5NWNETjk?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta Q2 2026 Earnings Preview \u2014 Street Expects $0.14 EPS", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxQLUw4M2pkMzh0RHY2VnVFTExUcUpyQ3IyTEQwMUVnVGJjNDFmbnNMT3BReF9hV3Jhci1LM195Z3gyVFhmMllBcm9rbkdobW5Ub05lM1FDaDd5UC1RN0o2bzRPZzRUeHl3WjFPVFZWT2d6d3RjVXlYank3dVUtNXhKV19ySHpKZkJoQmVWaFhn0gGOAUFVX3lxTFAtTDgzamQzOHREdjZWdUVMTFRxSnJDcjJMRDAxRWdUYmM0MWZuc0xPcFF4X2FXcmFyLUszX3lneDJUWGYyWUFyb2tuR2htblRvTmUzUUNoN3lQLVE3SjZvNE9nNFR4eXdaMU9UVlZPZ3p3dGNVeVhqeTd1VS01eEpXX3JIekpmQmhCZVZoWGc?oc=5", "source_name": "AlphaStreet", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Azenta (AZTA) Investment Narrative Is Shifting As Analysts Recut Valuation Targets", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQZ2M0eVlxMjBnOUJDNGdfUHVmN1ljWWg4Wk9malhoOGczNG44RG9CNTNfSXpZaWptV1RRV2Y1QWJhaGFKLWN4aTlvWlZhWnNWTTlmNzlVSW5wM25ZeG9rS0FQenViNU1YYkZEV1EyaXlMV25ua0JOLWVoWkgyd0hqcHIyc3ZsaFprTWRvQjQ4cE1TdlhaMXVHV3dfcEdzODQzM3JYeEstZ25Wdw?oc=5", "source_name": "Market source", "published_at": "2026-05-03T07:00:00+00:00", "published_display": "03 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Azenta (AZTA) Valuation After Recent Share Price Volatility", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPVWsya1RXcG1BME16dlFKanI1NjNCNmFUdndYUlpoNHpabG1lV0lJRzhTX3BjdDJ3OGtWMzUzY25TZWNiMVRoY09EamdRZ3lfb3pLYjBYTFhBUXlkUGRqQldPNi1DbTdBRHZBRzhiekJrOEpPOW5Rck1fOUVMQ00ta0lHb0xRdTFJd2ZYUmoyMWY0RnVUaUZMZnhIVDRHdTRUTUVBcV9n?oc=5", "source_name": "Market source", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta (AZTA) Fell on Operational Challenges and Uneven Execution", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQRTNTZmFtOGJRQmU4dUpUZVB5eC1GbGZOWG9ScWZndHBHc2RJQl9DRFRocGxCUFlSUTdxR0lDRzE5c05rT3ZYdHFUMjhyMG1uRFZtYUFpUUNYN2dtc3ZrenZzdFdWUEdxVnJjTWhKLUR5UGZtYlVzcHlKdWR5b09WVHBCamQzN3BnTnpxZEMzT2xrUFFLZ29ueVRqMUp6RkUtRlJzRXNuaw?oc=5", "source_name": "Market source", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Azenta (AZTA) Valuation After A Short-Term Rebound And Longer-Term Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNYW1LR0pjQW92ZWVnejBfRkhuMWMwQlI4UXZIT2VMUUg3VE4wZDF5ZlBkQVAzQkgwTzQyUGhNNHFIY3VzSXJqRld5NVpWcmI1c21UbXNoRHI0U1U5WWh6OTNSVHdNSDRmSXRlek1qcXBGM2ZMSXhZMUZGU0ZJTVBsQUVJVGlyM0l3REt4aXhST24zMlNDQUdfaGZOTUR6Mk1BeTBVMA?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna Shares Plummet, What You Need To Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNTTYtaVhDaGh0R09DeEEtc0wzRGYxeGtWdERRT00tZXl2cG53VkdnWWh6UmdTMjRIOWVxQWh1Wmc2VFlYVWRFQ3VXdjEzT2JQV0Y5MEtsbHhWQlAwYnM3VUJjdUprZi1ncWlqNmpTcTVxVXplZmtXckx3WjZIQVp2VkVOVEpkUjF3WjlWU3JHbi01Nmh1dXdrTUFteDhaUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why is Azenta (AZTA) Trading So Low Despite Strong Balance Sheet", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOaGhNVzZGRE1HWnlXR0F0UXdPV3NTNXVpMkNPNFNSbUp1MHlwNVNDcENOSmZ2M2dyYy1oeGlDbDkySWV6OVk3Nk16VjhZREFLcTFrdVZLcDRGRXhwb3FqRmxIUkxaZEJYUzV3WUcxUzRHM3NTTFBuVW5Qb0gzRk0yYl9hQWg3aVl4dm5abHA5QWxRVkc3WDd6N3VrbXFIQQ?oc=5", "source_name": "Kavout | AI", "published_at": "2026-03-25T01:54:47+00:00", "published_display": "25 Mar 2026 01:54", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Has Azenta (AZTA) Fallen Too Far After Recent Share Price Weakness?", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE94aUlyT2lBVEVacGFSYTByMlFMUWRmaTdYcW5uQWlZTUxEN19wTEJuLVd3MU1SMXdaVWRZZVR1NldfRzFmMjV5MWNMTGZTN0JtZ1pac25yUmVIb2Z6WmNDSWtySXllV29aLWlGSnd0UUE1NHZaeDU3em85LWg?oc=5", "source_name": "Market source", "published_at": "2026-03-14T07:00:00+00:00", "published_display": "14 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace, Revvity, Azenta, Bio-Techne, and Oscar Health Stocks Trade Down, What You Need To Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNWjVYSmRLMFdQZ3I2ZkRNeEo5aFBFdVhSV3hvNXNfRzFRMjMybkd1aTF2d19KREI3dUJVa2d4VjJSSFc1RVFsa3JCZHhwM3JHeWVJQmlPOVpzd1RGMFE3M3R3dHRPY2JmYmw0Xy1mWFV3OHVoNkx1VVNmRE9qU1U1YjFOMnp4UQ?oc=5", "source_name": "Market source", "published_at": "2026-02-23T08:00:00+00:00", "published_display": "23 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does Azenta (AZTA) Earnings, Buyback Pause, and Board Change Hint at a Strategic Crossroads?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNWldvazlRTkd1Q09MOE9vMVdvSkxCTWh0d3p6aWVSeVhjV0t2OUQxbnA1NVdKQkI0Z1dkR3dDN2NXWmEwRG9vTjBHdnZyRE4yZTZvaUcxN1R3LXpwMzU4Tjk5QjhEckFOMElYSHFibzZCaUJLVjZ4TFJGZFh2WnFEOUMyZUFCZw?oc=5", "source_name": "Market source", "published_at": "2026-02-09T08:00:00+00:00", "published_display": "09 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Azenta (AZTA) Stock Trades Down, Here Is Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxQLThMcXM4dnBfMGRyR0E3M195RU9qcVJHMzFxQmdBRXJzd212THpJamVMcm9VUUh2VjBfeVNpcVEzVlpGNHY2eEt4NHlrX2dGSVZFM3V2Z05makMtZWkyOHF3dTk5M3l3YzVxTk12akZfOTROUWRvUGRLMHhzeXgwUw?oc=5", "source_name": "Market source", "published_at": "2026-02-04T08:00:00+00:00", "published_display": "04 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 93, "total_relevant": 54, "sentiment_summary": {"positive": 11, "negative": 6, "neutral": 37, "score": 51, "total": 54, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 75, "events": [{"event": "general", "label": "Market update", "weight": 12.65, "count": 23}, {"event": "earnings", "label": "Earnings", "weight": 9.9, "count": 18}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 2.9, "count": 4}, {"event": "liquidity", "label": "Balance sheet", "weight": 2.75, "count": 5}, {"event": "guidance", "label": "Guidance", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 11, "negative_events": 6}, "market_context": {"has_market_context": true, "latest_close": 25.36, "latest_week": "2026-07-10", "one_week_move": -1.9, "four_week_move": 12.3, "twelve_week_move": 1.3, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.490499, "market_dynamics_buy_signal": false, "relative_strength": -25.188291, "fair_value_gap": -40.0, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 48.3136, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.9% over one week, +12.3% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 57, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 12}, {"label": "TradingView", "count": 9}, {"label": "PR Newswire", "count": 5}, {"label": "simplywall.st", "count": 3}, {"label": "Investing.com", "count": 3}, {"label": "Investing.com Nigeria", "count": 2}, {"label": "Moomoo", "count": 2}, {"label": "Simply Wall Street", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 54}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 23}, {"label": "Earnings", "count": 18}, {"label": "Balance sheet", "count": 5}, {"label": "Regulatory and legal", "count": 4}, {"label": "Guidance", "count": 2}, {"label": "Deals and strategy", "count": 1}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "75/100 classification confidence."}, {"label": "Company focus", "value": "54", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-1.9% over one week, +12.3% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Azenta announces completion of B Medical Systems sale to Thelema S.a r.l; Whitestone Group acquires a 40% Stake in Thelema S.a r.l, a Special Purpose Vehicle (SPV) established for the ownership of B Medical Systems"}], "updated_at": "2026-07-16T08:52:24.021263+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}